Cover Image
市場調查報告書

全球HIV、愛滋病檢驗市場

Global HIV-AIDS Testing Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 301115
出版日期 內容資訊 英文 99 Pages
訂單完成後即時交付
價格
Back to Top
全球HIV、愛滋病檢驗市場 Global HIV-AIDS Testing Market 2014-2018
出版日期: 2014年04月25日 內容資訊: 英文 99 Pages
簡介

愛滋病是由於人體的免疫疾病功能階段性降低所引起的病,這個免疫力低下,是HIV病毒攻擊白血球,其中的CD4或幫手T細胞的亞族群而引起。愛滋病/HIV檢驗產品,是為了確認血液中是否有HIV的醫療產品。這包含HIV抗體檢驗、抗原(P24)檢驗、PCR檢驗等許多種類。全球HIV、愛滋病檢驗市場預計從2013年到2018年,以5.43%的年複合成長率發展。

本報告提供全球HIV、愛滋病檢驗市場現況與展望調查分析、目前市場環境、各檢驗類型、區域區隔趨勢、檢驗產品的購買標準、影響市場成長因素、競爭環境、市場佔有率、主要供應商的企業資料、產業策略等彙整資料,為您概述為以下內容。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 HIV和愛滋病概要

  • HIV的類型

第6章 簡介

第7章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第8章 市場區隔:各類別

  • 全球HIV、愛滋病檢驗市場:各類別

第9章 HIV檢驗的類型

  • 抗體檢驗
  • 抗原檢驗
  • PCR檢驗

第10章 地區區分

  • 全球HIV、愛滋病檢驗市場:各地區

第11章 HIV感染者人口多的國家前20國

第12章 購買標準

第13章 市場促進因素

第14章 成長推進因素與其影響

第15章 市場上課題

第16章 成長推進因素及課題的影響

第17章 市場趨勢

第18章 市場趨勢與其影響

第19章 供應商環境

  • 競爭模式
    • 主要消息
    • M&A
    • 市場佔有率分析
    • 其他的關注供應商

第20章 主要供應商分析

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Hologic Inc.
  • Ortho-Clinical Diagnostics Inc.
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics Inc.
    • 主要資料
    • 產業概要
    • 重要資訊
    • 產業策略
    • SWOT分析等

第21章 本系列的其他報告

目錄
Product Code: IRTNTR3468

About HIV-AIDS Testing

AIDS is a condition caused due to the gradual weakening of the human body's immune system. This weakening is caused by a virus called HIV, which attacks the body's white blood cells, specifically a subset called CD4 or helper T cells. AIDS/HIV testing devices are medical devices that are used to determine the presence of HIV in human blood. A number of testing devices are available including the HIV antibody test, the Antigen (P24) test, and the PCR test.

TechNavio's analysts forecast the Global HIV-AIDS Testing market will grow at a CAGR of 5.43 percent over the period 2013-2018.

Covered in this Report

The Global HIV-AIDS Testing market can be divided into three segments: HIV-AIDS Screening Assays, HIV-AIDS Confirmatory Assays, and HIV-AIDS Monitoring Assays.

TechNavio's report, the Global HIV-AIDS Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global HIV-AIDS Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Hologic Inc.
  • Ortho-Clinical Diagnostics Inc.
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics Inc.

Other Prominent Vendors

  • bioMerieux SA
  • Calypte Biomedical Corp.
  • Fujirebio Diagnostics Inc.
  • Medical Services International Inc.
  • MedMira Laboratories Inc.
  • OraSure Technologies Inc.
  • Quest Diagnostics Inc.
  • Trinity Biotech plc

Market Driver

  • Increase in Number of People Prone to HIV/AIDS.

For a full, detailed list, view our report.

Market Challenge

  • Intense Competition among Vendors.

For a full, detailed list, view our report.

Market Trend

  • Adoption of AIDS/HIV Workplace Policies by Companies.

For a full, detailed list, view our report.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. HIV and AIDS Overview

  • 05.1.1. Types of HIV

06. Introduction

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Market Segmentation by Category

  • 08.1. Global HIV-AIDS Testing Market by Category

09. Types of HIV Tests

  • 09.1.1. Antibody Tests
  • 09.1.2. Antigen Tests
  • 09.1.3. PCR Tests

10. Geographical Segmentation

  • 10.1. Global HIV-AIDS Testing Market by Geographical Segmentation

11. Top 20. Countries with HIV Infected Population

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Market Share Analysis 2013
  • 19.3. Other Prominent Vendors

20. Key Vendor Analysis

  • 20.1. Abbott Laboratories
    • 20.1.1. Key Facts
    • 20.1.2. Business Description
    • 20.1.3. Business Segmentation
    • 20.1.4. Business Strategy
    • 20.1.5. Revenue Segmentation
    • 20.1.6. Revenue Comparison 2012 and 2011
    • 20.1.7. Geographical Segmentation
    • 20.1.8. Key Information
    • 20.1.9. SWOT Analysis
    • 20.1.10. Strengths
    • 20.1.11. Weakness
    • 20.1.12. Opportunities
    • 20.1.13. Threats
  • 20.2. Bio-Rad Laboratories Inc.
    • 20.2.1. Key Facts
    • 20.2.2. Business Description
    • 20.2.3. Business Segmentation
    • 20.2.4. Business Strategy
    • 20.2.5. Revenue Segmentation of Bio-Rad Laboratories Inc.
    • 20.2.6. Revenue Comparison FY2012 and FY2011
    • 20.2.7. Bio-Rad Laboratories Inc. by Geographical Segmentation
    • 20.2.8. Key Information
    • 20.2.9. SWOT Analysis
    • 20.2.10. Strengths
    • 20.2.11. Weakness
    • 20.2.12. Opportunities
    • 20.2.13. Threats
  • 20.3. Hologic Inc.
    • 20.3.1. Key Facts
    • 20.3.2. Business Description
    • 20.3.3. Business Segmentation
    • 20.3.4. Business Strategy
    • 20.3.5. Revenue Segmentation
    • 20.3.6. Revenue Comparison FY2012 and FY2013
    • 20.3.7. Geographical Segmentation
    • 20.3.8. Key Information
    • 20.3.9. SWOT Analysis
    • 20.3.10. Strengths
    • 20.3.11. Weaknesses
    • 20.3.12. Opportunities
    • 20.3.13. Threats
  • 20.4. Ortho-Clinical Diagnostics Inc.
    • 20.4.1. Key Facts
    • 20.4.2. Business Overview
    • 20.4.3. Key Information
    • 20.4.4. SWOT Analysis
    • 20.4.5. Strengths
    • 20.4.6. Weakness
    • 20.4.7. Opportunities
    • 20.4.8. Threats
  • 20.5. Roche Diagnostics
    • 20.5.1. Key Facts
    • 20.5.2. Business Description
    • 20.5.3. Business Segmentation
    • 20.5.4. Revenue Segmentation
    • 20.5.5. Geographical Segmentation
    • 20.5.6. Business Strategy
    • 20.5.7. Key Information
    • 20.5.8. SWOT Analysis
    • 20.5.9. Strengths
    • 20.5.10. Weaknesses
    • 20.5.11. Opportunities
    • 20.5.12. Threats
  • 20.6. Siemens Healthcare Diagnostics Inc.
    • 20.6.1. Key Facts
    • 20.6.2. Business Overview
    • 20.6.3. Key Information
    • 20.6.4. Business Strategy
    • 20.6.5. SWOT Analysis
    • 20.6.6. Strengths
    • 20.6.7. Weaknesses
    • 20.6.8. Opportunities
    • 20.6.9. Threats

21. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global HIV-AIDS Testing Market Overview
  • Exhibit 3: Global HIV-AIDS Testing market 2013-2018 (US$ billion)
  • Exhibit 4: Global HIV-AIDS Testing Market Segmentation by Category
  • Exhibit 5: Global HIV-AIDS Testing Market Segmentation by Category 2013
  • Exhibit 6: Types of HIV Tests
  • Exhibit 7: Global HIV-AIDS Testing Market by Geographical Segmentation 2013
  • Exhibit 8: Top 20 HIV Infected Countries with HIV Infected Population 2012
  • Exhibit 9: Business Segmentation of Abbott Laboratories
  • Exhibit 10: Revenue Segmentation of Abbott Laboratories 2012
  • Exhibit 11: Revenue Comparison 2012 and 2011 (US$ million)
  • Exhibit 12: Abbott Laboratories by Geographical Segmentation 2012
  • Exhibit 13: Business Segmentation of Bio-Rad Laboratories Inc.
  • Exhibit 14: Revenue Segmentation of Bio-Rad Laboratories Inc. FY2012
  • Exhibit 15: Revenue Comparison 2012 and 2011(US$ million)
  • Exhibit 16: Bio-Rad Laboratories Inc. by Geographical Segmentation 2012
  • Exhibit 17: Business Segmentation of Hologic Inc.
  • Exhibit 18: Revenue Segmentation of Hologic Inc. 2013
  • Exhibit 19: Revenue Comparison FY2012 and FY2013 (US$ million)
  • Exhibit 20: Hologic Inc. by Geographical Segmentation 2013
  • Exhibit 21: Business Segmentation of Roche Diagnostics
  • Exhibit 22: Revenue Segmentation of Roche Diagnostics FY2013
  • Exhibit 23: Roche Diagnostics by Geographical Segmentation FY2013
Back to Top